Palliative, adjuvante Therapieoptionen beim Pankreaskarzinom unter Berücksichtigung der regionalen Chemotherapiemöglichkeiten

Link, K. H.; Gansauge, Frank; Schoenberg, M. H.; Staib, Ludger; Formentini, A.; Leder, Eckhart Dietrich; Fortnagel, G.; Warszawski, N.; Lutz, M. B.; Gress, Th; Beger, H. G.

doi:10.1007/bf02621323

Search citation statements

Order By: Relevance

Paper Sections

Select...

Pankreas Duktales Adenokarzinom1

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Year Published

1999

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 49 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…fünfthäufigste Karzinomtodesursache in der westlichen Welt [47,48]. fünfthäufigste Karzinomtodesursache in der westlichen Welt [47,48].…”

Section: Pankreas Duktales Adenokarzinomunclassified

Radiologisches Staging von Leber- und Pankreasmalignomen

Schima¹,

Ba‐Ssalamah²

1999

Der Radiologe

View full text Add to dashboard Cite

Modern therapeutic strategies can improve survival of patients with pancreatic or liver malignancies. A prerequisite is thorough radiologic assessment of these patients. A variety of radiologic techniques are available, such as ultrasound, contrast-enhanced CT, CTAP, contrast-enhanced MRI, and endoscopic ultrasound. In this review the advantages and weaknesses of the different techniques are presented in the staging of patients with HCC, cholangiocarcinoma, suspected liver metastases, and pancreatic carcinoma. In an era of economic restraints, funds are not flowing freely anymore for radiologic studies. We have to consider not doing so many different examinations for each patient. We have to decide in the future which diagnostic test we want to perform for detection and staging of a particular disease. For liver and pancreatic malignancies it is likely to be MRI that will take this role.

show abstract

“…fünfthäufigste Karzinomtodesursache in der westlichen Welt [47,48]. fünfthäufigste Karzinomtodesursache in der westlichen Welt [47,48].…”

Section: Pankreas Duktales Adenokarzinomunclassified